suven-pharmaceuticals-ltd
Home
Suven Pharmaceuticals Ltd
SUVENPHAR Share Price
BSE:
NSE:SUVENPHAR
SUVENPHAR Share Price
BSE:
NSE:SUVENPHAR
Pharmaceuticals
Large Cap
₹-
0 (0%)
Market Cap
₹32,394.66 Cr
PE Ratio
133.25
Suven Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Suven Pharmaceuticals Ltd Fundamentals
Suven Pharmaceuticals Ltd Delivery and Volume
About Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs
| Name | Designation |
|---|---|
| Shweta Jalan | Non Executive Director |
| U B Pravin Rao | Independent Director |
| Venkatanaga Kali Vara Prasad Raju Vetukuri | Managing Director |
| Pankaj Patwari | Non Executive Director |
| Matangi Gowrishankar | Independent Director |
| Vinod Rao | Independent Director |
| K G Ananthakrishnan | Independent Director |
| VIVEK SHARMA | Executive Chairman & Director |
| Kundan Kumar Jha | Company Sec. & Compli. Officer |
| Jaishankar Krishnan | Additional Director |
| Vinod Padikkal | Additional Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Suven Pharmaceuticals Ltd FAQs
How do I Buy Suven Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Suven Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Suven Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Suven Pharmaceuticals Ltd's share price is ₹1270 as of 2024-12-15.
What is the PE ratio of Suven Pharmaceuticals Ltd?
Suven Pharmaceuticals Ltd's P/E ratio is 133.25 times as of 2024-12-15.
What is the PB ratio of Suven Pharmaceuticals Ltd?
Suven Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 16.37, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Suven Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Suven Pharmaceuticals Ltd's market capitalization is ₹32394.66 Cr as on 2024-12-15.
What is the ROE of Suven Pharmaceuticals Ltd?
The current financial records of Suven Pharmaceuticals Ltd show a 14.31% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Suven Pharmaceuticals Ltd?
According to Suven Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹445.76, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Suven Pharmaceuticals Ltd?
The 52-week high/low price of a Suven Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Suven Pharmaceuticals Ltd's 52-week high and low as of 2024-12-15 are ₹1282.75 and ₹1245, respectively.
